M&A Lawyers Singapore 2026: CCS Merger Procedure Guidelines & Form M1 Timelines

The Competition and Consumer Commission of Singapore (CCS) introduced revised Merger Procedure Guidelines and an updated Form M1 that took effect on 1 May 2026, reshaping how deal teams approach merger notifications in one of Asia’s most active M&A markets. For M&A lawyers Singapore practitioners rely on, the changes bring a new streamlined Phase 1 review track of 25 working days for straightforward cases, expanded data requirements within Form M1, and clearer guidance on pre-notification discussions (PNDs). These revisions follow a public consultation process and are designed to reduce information burdens on third parties while giving CCS more targeted data earlier in the review cycle.

This guide walks in-house counsel, private equity deal teams and corporate finance advisors through every practical step, from deciding whether to file, to drafting Form M1 entries, to coordinating concurrent filings across multiple jurisdictions.

Key Takeaways for Deal Teams

• New streamlined Phase 1 track. Straightforward notifications can now expect a CCS decision within 25 working days, down from the standard 30 working-day Phase 1 timeline.
• Updated Form M1 fields. The revised form requires more detailed market-definition input and expanded customer and supplier lists, top 10 rather than top 5 where applicable.
• Reduced third-party burden. CCS has clarified the scope of information it expects from third parties, which should accelerate feedback loops during review.
• Pre-notification discussions encouraged. The revised Guidelines place greater emphasis on PNDs, particularly for transactions with complex market dynamics or cross-border dimensions.

What Changed, CCS Merger Procedure Guidelines (Effective 1 May 2026)

The revised CCS Merger Procedure Guidelines represent the most significant procedural overhaul to Singapore’s merger control framework since the Competition Act’s merger provisions came into force. The changes, announced by CCS and effective 1 May 2026, target three areas: review speed, filing quality and engagement transparency.

At the core of the reform is the introduction of a streamlined Phase 1 review track. Under the previous framework, all Phase 1 reviews followed a single 30 working-day indicative timeline regardless of complexity. The revised Guidelines now differentiate between straightforward mergers, those with limited overlaps and no significant vertical relationships, and more complex transactions. Straightforward cases are eligible for the 25 working-day streamlined track, provided the Form M1 is complete at the point of acceptance.

Alongside the faster track, CCS has reduced certain documentary requirements for third-party market participants contacted during review, responding to feedback that the prior process imposed disproportionate burdens on customers and competitors asked to provide data. The revised Guidelines also formalise best practices for pre-notification discussions, setting out what CCS expects parties to bring to a PND meeting and how early engagement can shorten the formal review period.

Why CCS Made the Changes, Policy Drivers and Consultation Summary

The revisions followed a public consultation during which CCS received feedback from law firms, industry associations and multinational corporations active in Singapore. Industry observers note that the consultation responses consistently highlighted two concerns: the length of the review process for non-controversial transactions, and the volume of information demanded from third parties who had no direct stake in the filing outcome. CCS responded by creating a tiered review system and by committing to more proportionate third-party engagement. The likely practical effect will be that well-prepared filings in unconcentrated markets move through the system materially faster, freeing CCS resources for genuinely complex cases.

Does Your Deal Need a Form M1? Notification Thresholds and Scope

Singapore operates a voluntary merger notification regime under Section 54 of the Competition Act. Unlike the European Union or many ASEAN neighbours, there are no mandatory turnover-based notification thresholds that automatically trigger a filing obligation. Instead, merger control in Singapore relies on parties self-assessing whether their transaction could result in a substantial lessening of competition (SLC) in any market in Singapore.

In practice, the voluntary nature of the regime does not mean that notification is optional in the strategic sense. CCS retains the power to investigate and challenge mergers that have already been implemented, and has done so. The practical notification thresholds that experienced competition counsel apply are based on indicators of potential competitive harm rather than bright-line turnover figures. Parties should seriously consider filing a Form M1 where any of the following conditions exist:

• Combined market share exceeds 40%. A combined entity holding more than 40% in any relevant market in Singapore will attract heightened scrutiny.
• Combined share between 20% and 40% with an increment of significance. Transactions that push combined shares above 20% and involve a meaningful increment (typically 5% or more) warrant careful analysis.
• Significant vertical relationships. Where the merged entity would be both a major supplier and a major customer in related upstream and downstream markets, foreclosure concerns may arise.
• Critical infrastructure or regulated sectors. Transactions in telecommunications, media, energy, transport or financial services often attract parallel regulatory attention, making CCS notification prudent for holistic clearance management.

Common Triggers for CCS Scrutiny

Beyond market share arithmetic, CCS has historically focused on structural features that could enable coordinated effects or unilateral price increases. Deals that remove a particularly disruptive or innovative competitor, transactions in markets with high barriers to entry, and mergers creating significant buyer power over fragmented suppliers all raise flags. Industry observers expect CCS to continue refining its approach to digital markets, where traditional market-share metrics may understate competitive significance. For borderline cases, the revised Guidelines now expressly encourage parties to seek a PND before deciding whether to file, a pragmatic acknowledgement that voluntary regimes work best when the regulator and parties maintain open lines of communication.

CCS Form M1, New Content Requirements and Step-by-Step Filing Checklist

The updated CCS Form M1, effective 1 May 2026, is the central document in any merger notification. It serves simultaneously as the information-gathering template, the analytical framework and the public record (in non-confidential form) of the proposed transaction. The revisions to Form M1 demand greater analytical depth in several areas while also streamlining sections that CCS found generated low-value data under the prior template.

The form is structured in sequential sections. Parties should expect to invest significant time in market-definition analysis and competitive-effects assessment, these sections have been expanded substantially. Below is a practical filing checklist mapped to the major sections of the updated Form M1.

Form M1 Filing Checklist

• Section 1, Executive summary. A concise overview of the transaction (recommended length: 150–250 words) covering the parties, transaction structure, strategic rationale and a preliminary view on competitive effects. This section should be drafted to serve as the non-confidential public summary.
• Section 2, Parties and transaction structure. Full legal names, corporate structures, ultimate beneficial ownership and a clear description of what is being acquired (shares, assets, or business undertakings). Include organisational charts for complex group structures.
• Section 3, Relevant markets. Detailed market-definition analysis covering product and geographic dimensions. The updated form now requires parties to articulate their proposed market definition and provide supporting evidence, including demand-side and supply-side substitutability analysis. CCS expects this section to reflect genuine analytical rigour, not merely a recitation of the parties’ preferred framing.
• Section 4, Market shares and concentration data. Provide market share estimates for each relevant market for the past three years, with sources identified. Include both volume-based and value-based shares where available.
• Section 5, Top customers and suppliers. The updated Form M1 now requires details of the top 10 customers and top 10 suppliers (expanded from the previous top 5) for each party in each relevant market, including contact details and approximate transaction volumes.
• Section 6, Horizontal overlaps and vertical relationships. A structured analysis of where the parties’ activities overlap horizontally and where vertical supply relationships exist. Include a competitive-effects assessment addressing unilateral and coordinated effects theories of harm.
• Section 7, Efficiencies and countervailing factors. Any claimed efficiencies, buyer power arguments, or ease-of-entry contentions that parties believe offset potential competition concerns.
• Section 8, Supporting documents. Internal board papers, strategy documents, market studies and any reports prepared by or for the parties that discuss competitive conditions in the relevant markets. CCS guidance on submission documents sets out accepted electronic formats and filing protocols.
• Confidentiality schedule. A separate schedule identifying all information for which confidential treatment is claimed, with justifications for each claim. CCS requires parties to prepare a non-confidential version of the entire Form M1 suitable for disclosure to third parties.

Sample Non-Confidential Executive Summary Structure

A well-drafted non-confidential executive summary for Form M1 should follow a clear four-part structure. First, identify the acquirer and target by name and describe the transaction mechanism (share purchase, asset acquisition or merger). Second, state the anticipated completion date and any conditions precedent. Third, provide a high-level description of the parties’ activities in Singapore, avoiding commercially sensitive revenue figures but indicating the general sectors and customer segments served. Fourth, offer a preliminary competitive assessment explaining why the transaction is unlikely to result in a substantial lessening of competition, referencing low combined market shares, the presence of strong competitors, or the absence of horizontal overlaps.

The recommended length is 150–250 words. Aim for clarity over comprehensiveness, CCS uses this summary to brief third parties during the market consultation phase, so it should be accurate and self-contained without revealing sensitive deal terms.

Attachments and Supporting Evidence

The revised submission guidance specifies that supporting documents should be submitted electronically in searchable PDF format. Key attachments include signed copies of the transaction agreements, organisational charts, market share spreadsheets (preferably in Excel format for CCS analyst use), customer and supplier contact lists, and any relevant internal strategy or board documents that discuss competitive conditions. Parties should also prepare geographic market maps where relevant, particularly for transactions involving physical distribution networks or location-sensitive services. Early preparation of these attachments, ideally in parallel with the Form M1 drafting process, is one of the most effective ways to avoid delays during the completeness review stage.

Merger Timelines and Review Tracks, Phase 1 Streamlined Track and Phase 2

Understanding CCS merger timelines is essential for deal structuring, particularly when competition clearance is a condition precedent to closing. The revised Guidelines introduce a two-tier Phase 1 framework alongside the existing Phase 2 investigation process.

The streamlined Phase 1 track is designed for transactions where the Form M1 is complete at acceptance, the relevant markets are well-defined, and there are no material competitive concerns apparent on the face of the filing. Industry observers expect this track to be available primarily for transactions with limited horizontal overlaps and combined market shares well below 40%. CCS retains discretion to move a notification from the streamlined track to the standard track if issues emerge during review.

What Extends Merger Timelines

Several factors routinely push review periods beyond the indicative working-day targets. Complex or contested market-definition questions, particularly in digital, platform or multi-sided markets, often require additional rounds of information exchange. Third-party feedback that raises concerns not anticipated in the Form M1 can trigger supplementary RFIs. Where CCS identifies potential competition concerns, the shift from Phase 1 to Phase 2 resets the clock entirely, adding up to 120 working days (and potentially more if the parties offer remedies that themselves require market testing). Parties engaged in remedies negotiations should expect the overall process to take six months or longer from filing to final decision.

Practical Tips to Meet Deadlines

The single most effective way to accelerate CCS review is to submit a genuinely complete Form M1 at the outset. Pre-load all supporting documents, ensure customer and supplier contact details are current and verified, and provide market share data in both PDF and editable spreadsheet formats. Designate a single point of contact within the deal team, typically competition counsel, to manage all CCS communications and coordinate responses to RFIs within the tight turnaround windows that CCS typically sets (often five to ten working days). Where the transaction also requires clearance in other jurisdictions, factor in additional time for confidentiality waiver coordination.

Cross-Border M&A Singapore, Multi-Jurisdictional Filing Coordination

Transactions involving Singapore targets or acquirers frequently trigger parallel merger control filings in multiple jurisdictions. Effective cross-border coordination is critical to avoid delays, conflicting information submissions and regulator concerns about transparency. The revised CCS submission guidance includes updated confidentiality waiver templates designed to facilitate information sharing between CCS and foreign competition authorities.

The key jurisdictions that Singapore-linked M&A transactions most commonly engage alongside CCS include:

• European Commission (EC). Transactions meeting EU turnover thresholds require a parallel Form CO filing. Timing alignment is critical, EC Phase I runs for 25 working days from notification, closely matching the new CCS streamlined track.
• UK Competition and Markets Authority (CMA). Post-Brexit, UK filings are separate from EC proceedings. CMA Phase 1 runs for up to 40 working days.
• US Department of Justice (DOJ) / Federal Trade Commission (FTC). HSR Act filings follow a 30-calendar-day initial waiting period, though early termination is available for non-controversial deals.
• ASEAN national authorities. Malaysia (MyCC), Indonesia (KPPU), Thailand (OTCC), the Philippines (PCC) and Vietnam (VCA) each have distinct merger control regimes with varying thresholds, timelines and notification triggers. Multi-country ASEAN deals require jurisdiction-by-jurisdiction analysis.

Templates for Confidentiality Waivers and Regulator Communication

CCS provides template confidentiality waivers that parties can execute to permit CCS to share information with, and receive information from, foreign competition authorities reviewing the same transaction. Early execution of these waivers, ideally at the point of Form M1 submission, avoids a common bottleneck: CCS and a foreign authority reaching the same analytical question simultaneously but being unable to coordinate because waiver authorisations are still pending. Deal teams should prepare a master waiver schedule listing all jurisdictions where filings are being made, the relevant authority in each, and the scope of information the parties are comfortable having shared.

Where parallel filings are anticipated, consider submitting the CCS Form M1 and the corresponding foreign filing on the same day or within the same week to keep review timelines broadly synchronised.

As an illustrative example, consider a private equity fund headquartered in Singapore acquiring a European logistics company with operations across ASEAN. The deal triggers filings with CCS, the European Commission, CMA and potentially KPPU and PCC. A well-coordinated filing strategy would involve submitting the CCS Form M1 and the EC Form CO within the same week, pre-executing waivers for all five authorities, and designating one global competition counsel team to serve as the single point of contact across all proceedings. Early indications suggest that CCS is increasingly receptive to this kind of coordinated approach, particularly where the parties demonstrate transparency about parallel filings at the PND stage.

Practical Drafting Guidance for M&A Lawyers Singapore Transactions Require

Drafting a Form M1 that is both analytically rigorous and strategically sound is one of the most important tasks competition counsel perform in a Singapore merger notification. The updated form demands careful attention to market-definition framing, customer and supplier disclosure levels, and the balance between transparency and legitimate confidentiality claims.

The following comparison table maps the typical disclosure expectations by entity type, helping deal teams calibrate their Form M1 drafting approach to the specific transaction structure.

When framing market definitions, present your preferred definition clearly but acknowledge plausible alternatives. CCS will form its own view, and a filing that ignores obvious alternative market definitions risks appearing adversarial. For customer lists, verify all contact details before submission, outdated contacts generate unnecessary RFIs and slow the review. For confidentiality claims, be proportionate: over-claiming confidentiality frustrates the review process and may prompt CCS to challenge claims, consuming time that could be spent on substantive analysis.

Recommended Pre-Notification Strategy for Deal Teams

The revised CCS Merger Procedure Guidelines place greater emphasis on pre-notification discussions as a mechanism to improve filing quality and reduce formal review times. A well-executed pre-notification strategy is now one of the most valuable tools available to deal teams navigating merger control in Singapore.

CCS encourages parties to request a PND at least four to six weeks before the anticipated Form M1 submission date. The recommended PND agenda should cover:

• Transaction overview. A brief description of the deal structure, parties, and anticipated timeline.
• Preliminary market definition. The parties’ proposed approach to defining relevant product and geographic markets, including any areas of uncertainty.
• Identified overlaps and vertical relationships. A candid preliminary assessment of where competitive issues might arise.
• Filing timeline and cross-border coordination. Whether parallel filings are anticipated, in which jurisdictions, and the parties’ proposed sequence.
• Streamlined track eligibility. Whether the parties believe the transaction qualifies for the 25 working-day streamlined Phase 1 track, and why.

Internally, deal teams should ensure that the decision to notify CCS, and the scope of the notification, is signed off by both the transaction’s commercial sponsor and competition counsel no later than the letter-of-intent stage. Engaging experienced M&A lawyers in Singapore at the earliest feasible point allows counsel to shape the deal documentation with notification requirements in mind, avoiding last-minute scrambles to assemble data that should have been gathered during due diligence. For borderline cases, where the SLC risk is arguable but not obvious, a PND is almost always the right first step, as CCS can provide informal guidance on whether a full Form M1 filing is warranted.

Conclusion, Navigating CCS Merger Control in 2026

The revised CCS Merger Procedure Guidelines and updated Form M1 represent a meaningful step toward a faster, more transparent merger review process in Singapore. Deal teams that invest in thorough preparation, completing detailed market-definition analysis, assembling expanded customer and supplier data, and engaging in pre-notification discussions, will be best positioned to secure competition clearance efficiently. For cross-border transactions, early coordination across jurisdictions and proactive use of confidentiality waivers are now essential components of any well-managed filing strategy. Experienced M&A lawyers in Singapore can help deal teams navigate these requirements, assess notification risk accurately, and build filings that meet CCS expectations from the outset. For tailored guidance on your specific transaction, consult the Global Law Experts Singapore lawyer directory.

Sources

1. Competition & Consumer Commission of Singapore, Revisions to CCS’s Merger Procedure Guidelines
2. CCS, Merger Notification Procedures
3. CCS, Form M1 (effective 1 May 2026)
4. CCS, Submission Documents
5. Concurrences, Analysis of the Revised Guidelines (March 2026)
6. Chambers, Singapore M&A Practice Guide
7. Lexology, Firm Alerts on Singapore Merger Control
8. ICLG / Drew & Napier, Merger Control 2026 Singapore Chapter